IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM PAR
Total 13F shares
9,425,171
Share change
-981,642
Total reported value
$27,240,982
Price per share
$2.89
Number of holders
46
Value change
-$2,624,467
Number of buys
12
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q3 2019

As of 30 Sep 2019, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,425,171 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, OXFORD ASSET MANAGEMENT LLP, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, and JPMORGAN CHASE & CO. This page lists 46 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.